연구동향 분석

EGFR and HER2 Expression in Papillary Thyroid Carcinoma

김용석 김정수 김용석 2018년

논문상세정보
    • 저자 김용석 김정수 김용석
    • 제어번호 105962631
    • 학술지명 The Koreran journal of Endocrine Surgery
    • 권호사항 Vol. 18 No. 4 [ 2018 ]
    • 발행처 대한갑상선-내분비외과학회
    • 자료유형 학술저널
    • 수록면 228-235
    • 언어 English
    • 출판년도 2018
    • 등재정보 KCI등재
    • 판매처
    유사주제 논문( 0)
인용/피인용

' EGFR and HER2 Expression in Papillary Thyroid Carcinoma' 의 참고문헌

  • Worldwide increasing incidence of thyroid cancer : update on epidemiology and risk factors
  • Thyroid cancer epidemiology and prognostic variables
    Sipos JA [2010]
  • The prevalence and prognostic value of BRAF mutation in thyroid cancer
    Kebebew E [2007]
  • The HER-2/neu oncogene in breast cancer: prognostic factor, predictive factor, and target for therapy
    Ross JS [1998]
  • Relation between Ki-67, ER, PR, Her2/neu, p21, EGFR, and TOP II-α expression in invasive ductal breast cancer patients and correlations with prognosis
    Yan J [2015]
  • Prognostic value of c-erbB-2 expression in papillary thyroid carcinoma
  • Prognostic significance of Ki-67 labeling index in papillary thyroid carcinoma
    Ito Y [2010]
  • Predicting outcome in papillary thyroid carcinoma: development of a reliable prognostic scoring system in a cohort of 1779 patients surgically treated at one institution during 1940 through 1989
    Hay ID [1993]
  • Mutations of the BRAF Gene in Papillary Thyroid Carcinoma in a Korean Population
    김경희 [2004]
  • MIB-1 index in thyroid tumors: a predictor of the clinical course in papillary thyroid carcinoma
    Kjellman P [2003]
  • Ki-67: Level of evidence and methodological considerations for its role in the clinical management of breast cancer: Analytical and critical review
    Luporsi E [2012]
  • Increasing incidence of thyroid cancer in the United States, 1973-2002
    Davies L [2006]
  • High expression of GPER1, EGFR and CXCR1 is associated with lymph node metastasis in papillary thyroid carcinoma
    Tang C [2014]
  • Her2/neu expression in poorly-differentiated and anaplastic thyroid carcinomas
    Ensinger C [2003]
  • Expression of phosphatase and tensin homolog, epidermal growth factor receptor, and Ki-67 in astrocytoma: a prospective study in a tertiary care hospital
    Saha R [2014]
  • Epidermal growth factor receptors: a functional perspective
  • Epidermal growth factor receptor overexpression is a marker for adverse pathologic features in papillary thyroid carcinoma
    Fisher KE [2013]
  • Epidermal growth factor receptor dependence in human tumors: more than just expression
    Arteaga CL [2002]
  • EGFR, pMAPK, pAkt and PTEN status by immunohistochemistry: correlation with clinical outcome in HER2-positive metastatic breast cancer patients treated with trastuzumab
    Gori S [2009]
  • EGFR and cancer prognosis
  • Differentiation, proliferation and retinoid receptor status of papillary carcinoma of the thyroid
    Tang W [2003]
  • Diagnostic changes as a reason for the increase in papillary thyroid cancer incidence in Geneva, Switzerland
  • Comparative study on overexpression of HER2/neu and HER3 in gastric cancer
    Zhang XL [2009]
  • Clinical responses to vemurafenib in patients with metastatic papillary thyroid cancer harboring BRAFV600E mutation
    Kim KB [2013]
  • Clinical predictors of right upper paraesophageal lymph node metastasis from papillary thyroid carcinoma
    Kim YS [2012]
  • BRAF mutation in papillary thyroid carcinoma: pathogenic role and clinical implications
    Tang KT [2010]
  • Association of EGFR and HER2 polymorphisms with risk and clinical features of thyroid cancer
    Rebaï M [2009]
  • Amplification of the human epidermal growth factor receptor 2 gene in differentiated thyroid cancer correlates with telomere shortening
    Sugishita Y [2013]
  • American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer
    Wolff AC [2007]